267 related articles for article (PubMed ID: 11858799)
21. On the mechanism of antidepressant-like action of berberine chloride.
Kulkarni SK; Dhir A
Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
[TBL] [Abstract][Full Text] [Related]
22. Nicotine, but not mecamylamine, enhances antidepressant-like effects of citalopram and reboxetine in the mouse forced swim and tail suspension tests.
Andreasen JT; Redrobe JP
Behav Brain Res; 2009 Jan; 197(1):150-6. PubMed ID: 18786574
[TBL] [Abstract][Full Text] [Related]
23. Behavioral and neurochemical effects of noradrenergic depletions with N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine in 6-hydroxydopamine-induced rat model of Parkinson's disease.
Srinivasan J; Schmidt WJ
Behav Brain Res; 2004 May; 151(1-2):191-9. PubMed ID: 15084435
[TBL] [Abstract][Full Text] [Related]
24. Studies on the acute and chronic effects of reboxetine on extracellular noradrenaline and other monoamines in the rat brain.
Sacchetti G; Bernini M; Bianchetti A; Parini S; Invernizzi RW; Samanin R
Br J Pharmacol; 1999 Nov; 128(6):1332-8. PubMed ID: 10578149
[TBL] [Abstract][Full Text] [Related]
25. Monoamine involvement in the antidepressant-like effect induced by P2 blockade.
Diniz CRAF; Rodrigues M; Casarotto PC; Pereira VS; Crestani CC; Joca SRL
Brain Res; 2017 Dec; 1676():19-27. PubMed ID: 28916441
[TBL] [Abstract][Full Text] [Related]
26. Further evidence that noradrenaline is not involved in the anti-immobility activity of chronic desipramine in the rat.
Esposito E; Ossowska G; Samanin R
Eur J Pharmacol; 1987 Apr; 136(3):429-32. PubMed ID: 3111866
[TBL] [Abstract][Full Text] [Related]
27. Clinical doses of citalopram or reboxetine differentially modulate passive and active behaviors of female Wistar rats with high or low immobility time in the forced swimming test.
Flores-Serrano AG; Vila-Luna ML; Álvarez-Cervera FJ; Heredia-López FJ; Góngora-Alfaro JL; Pineda JC
Pharmacol Biochem Behav; 2013 Sep; 110():89-97. PubMed ID: 23769836
[TBL] [Abstract][Full Text] [Related]
28. Serotonergic and noradrenergic pathways are required for the anxiolytic-like and antidepressant-like behavioral effects of repeated vagal nerve stimulation in rats.
Furmaga H; Shah A; Frazer A
Biol Psychiatry; 2011 Nov; 70(10):937-45. PubMed ID: 21907323
[TBL] [Abstract][Full Text] [Related]
29. Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine.
Szot P; Franklin A; Miguelez C; Wang Y; Vidaurrazaga I; Ugedo L; Sikkema C; Wilkinson CW; Raskind MA
Neuropharmacology; 2016 Feb; 101():76-86. PubMed ID: 26362360
[TBL] [Abstract][Full Text] [Related]
30. Regional Specific Modulation of Stress-Induced Neuronal Activation Associated with the PSD95/NOS Interaction Inhibitor ZL006 in the Wistar Kyoto Rat.
Sherwin E; Lennon A; Harkin A
Int J Neuropsychopharmacol; 2017 Oct; 20(10):833-843. PubMed ID: 28977524
[TBL] [Abstract][Full Text] [Related]
31. Modulation of MK-801-induced behaviour by noradrenergic agents in mice.
Harkin A; Morris K; Kelly JP; O'Donnell JM; Leonard BE
Psychopharmacology (Berl); 2001 Mar; 154(2):177-88. PubMed ID: 11314680
[TBL] [Abstract][Full Text] [Related]
32. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth.
Detke MJ; Lucki I
Behav Brain Res; 1996; 73(1-2):43-6. PubMed ID: 8788475
[TBL] [Abstract][Full Text] [Related]
33. L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats.
Miguelez C; Berrocoso E; Mico JA; Ugedo L
Neuropharmacology; 2013 Apr; 67():349-58. PubMed ID: 23211937
[TBL] [Abstract][Full Text] [Related]
34. The antidepressant activity of inositol in the forced swim test involves 5-HT(2) receptors.
Einat H; Clenet F; Shaldubina A; Belmaker RH; Bourin M
Behav Brain Res; 2001 Jan; 118(1):77-83. PubMed ID: 11163636
[TBL] [Abstract][Full Text] [Related]
35. Antagonism of the stress-induced increase in cortical norepinephrine output by the selective norepinephrine reuptake inhibitor reboxetine.
Dazzi L; Seu E; Cherchi G; Biggio G
Eur J Pharmacol; 2003 Aug; 476(1-2):55-61. PubMed ID: 12969749
[TBL] [Abstract][Full Text] [Related]
36. Chronic mild unpredictable stress after noradrenergic denervation: attenuation of behavioural and biochemical effects of DSP-4 treatment.
Harro J; Häidkind R; Harro M; Modiri AR; Gillberg PG; Pähkla R; Matto V; Oreland L
Eur Neuropsychopharmacol; 1999 Dec; 10(1):5-16. PubMed ID: 10647090
[TBL] [Abstract][Full Text] [Related]
37. Possible relationship of the locus coeruleus--hippocampal noradrenergic neurons to depression and mode of action of antidepressant drugs.
Kostowski W
Pol J Pharmacol Pharm; 1985; 37(6):727-43. PubMed ID: 3008134
[TBL] [Abstract][Full Text] [Related]
38. Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy.
Kumar U; Medel-Matus JS; Redwine HM; Shin D; Hensler JG; Sankar R; Mazarati A
Epilepsia; 2016 Mar; 57(3):506-15. PubMed ID: 26813337
[TBL] [Abstract][Full Text] [Related]
39. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment.
Harro J; Jossan SS; Oreland L
Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):425-31. PubMed ID: 1436127
[TBL] [Abstract][Full Text] [Related]
40. Hippocampal and prefrontal dopamine D1/5 receptor involvement in the memory-enhancing effect of reboxetine.
De Bundel D; Femenía T; DuPont CM; Konradsson-Geuken Å; Feltmann K; Schilström B; Lindskog M
Int J Neuropsychopharmacol; 2013 Oct; 16(9):2041-51. PubMed ID: 23672849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
